Agile stock craters after FDA declines to approve contraceptive patch for second time

The opposite of a Christmas miracle for Agile and its investors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.